Related Experiment Video
Updated: Aug 19, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP
Qiqi Cui1, Sang Kyun Lim, Bryan Zhao
1McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI 53706, USA.
Abstract:
Transforming growth factor beta (TGF-beta) stimulation results in the assembly of Smad-containing protein complexes that mediate activation or repression of TGF-beta responsive genes. To determine if disruption of specific Smad protein-protein interactions would selectively inhibit responses to TGF-beta or generally interfere with Smad-dependent signaling, we developed three Smad-binding peptide aptamers by introducing Smad interaction motifs from Smad-binding proteins CBP, FoxH1 and Lef1 into the scaffold protein E. coli thioredoxin A (Trx). All three classes of aptamers bound to Smads by GST pulldown assays and co-immunoprecipitation from mammalian cells. Expression of the aptamers in HepG2 cells did not generally inhibit Smad-dependent signaling as evaluated using seven TGF-beta responsive luciferase reporter genes. The Trx-xFoxH1b aptamer inhibited TGF-beta-induced expression from a reporter dependent on the Smad-FoxH1 interaction, A3-lux, by 50%. Trx-xFoxH1b also partially inhibited two reporters not dependent on a Smad-FoxH1 interaction, 3TP-lux and Twntop, and endogenous PAI-1 expression. Trx-Lef1 aptamer only inhibited expression of the Smad-Lef1 responsive reporter gene TwnTop. The Trx-CBP aptamer had no significant effect on reporter gene expression. The results suggest that Smad-binding peptide aptamers can be developed to selectively inhibit TGF-beta-induced gene expression.
Insights
Researchers developed peptide aptamers to selectively block transforming growth factor beta (TGF-beta) signaling pathways. These aptamers target specific Smad protein interactions, offering a precise method to inhibit TGF-beta-induced gene expression.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- Transforming growth factor beta (TGF-beta) signaling regulates gene expression via Smad protein complexes.
- Understanding Smad protein interactions is crucial for dissecting TGF-beta pathway regulation.
- Targeting specific protein-protein interactions offers a strategy for selective pathway modulation.
Purpose of the Study:
- To investigate whether disrupting specific Smad protein interactions can selectively inhibit TGF-beta responses.
- To develop and characterize Smad-binding peptide aptamers for targeted inhibition.
- To assess the specificity of aptamer-mediated inhibition of Smad-dependent signaling.
Main Methods:
- Designed peptide aptamers by incorporating Smad interaction motifs into a thioredoxin A scaffold.
- Validated aptamer binding to Smads using GST pulldown and co-immunoprecipitation assays.
- Assessed the effect of aptamer expression on TGF-beta responsive reporter gene activity in HepG2 cells.
Main Results:
- Three classes of Smad-binding peptide aptamers (Trx-CBP, Trx-FoxH1b, Trx-Lef1) were successfully generated and validated.
- Aptamer expression did not broadly inhibit Smad-dependent signaling across seven reporter genes.
- The Trx-FoxH1b aptamer selectively inhibited a Smad-FoxH1-dependent reporter (A3-lux) by 50% and partially affected other reporters.
- The Trx-Lef1 aptamer selectively inhibited a Smad-Lef1-dependent reporter (TwnTop).
Conclusions:
- Smad-binding peptide aptamers can be engineered for selective inhibition of specific TGF-beta signaling pathways.
- This approach provides a tool to dissect the roles of distinct Smad protein interactions in TGF-beta responses.
- Peptide aptamers represent a promising strategy for targeted modulation of cellular signaling.
Related Concept Videos
TGF - β Signaling Pathway
Hedgehog Signaling Pathway
The JAK-STAT Signaling Pathway

